x
- Home
- About Diabetes
- Services
- Diabetes Mellitus Modeling Solutions
- R&D Services for Diabetes Mellitus and Diabetic Complications
- By Drug Development Process
- About Us
- Careers
- Contact Us
Cat. No.: DMM-001060
| Status | Age | Sex |
|---|---|---|
|
|
|
| Product Overview | |
|---|---|
| Model Description | Exon 2 of Htr3a gene was deleted to generate Htr3a knockout mice. |
| Strain Name | C57BL/6J-Htr3Aem1 |
| Background Strain | C57BL/6J |
| SPF | Yes |
| Research Application | The product of this gene belongs to the ligand-gated ion channel receptor superfamily. This gene encodes subunit A of the type 3 receptor for 5-hydroxytryptamine (serotonin); a biogenic hormone that functions as a neurotransmitter; a hormone; and a mitogen. |
| Target Information | |
|---|---|
| Target Name | Htr3a |
| Synonyms | 5-HT3 |
| Gene ID | 15561 |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.
